Abstract

Genetic editing technologies, particularly CRISPR-Cas systems, have advanced rapidly, offering unprecedented possibilities to modify DNA with precision. These capabilities hold transformative potential in medicine, agriculture, and environmental management, including the prevention of hereditary diseases, enhancement of crop resilience, and control of vector-borne illnesses. However, such power raises profound ethical, legal, and social questions. Ethical frameworks for genetic editing are essential to balance scientific progress with moral responsibility. Central considerations include the distinction between somatic and germline editing, the principle of informed consent, the potential for unintended genetic consequences, and the equitable distribution of benefits. Somatic editing, typically affecting only the treated individual, is generally viewed as more ethically permissible than germline editing, which can alter heritable traits and affect future generations. Ethical analysis also draws on frameworks such as utilitarianism, which weighs potential benefits against risks; deontological ethics, which emphasizes duties and moral rules; virtue ethics, focusing on the moral character of scientists; and justice-based approaches, which address fairness and access. International governance is fragmented, with some nations imposing strict prohibitions while others adopt permissive stances, leading to calls for a global consensus on acceptable practices. Issues of "designer babies," genetic enhancement, and potential misuse for eugenics amplify public concern, making transparent dialogue between scientists, ethicists, policymakers, and communities crucial. Cultural perspectives further influence what is considered morally acceptable, underscoring the need for context-sensitive regulation. Future ethical frameworks must also account for emerging technologies such as base editing and gene drives, as well as the growing role of artificial intelligence in genetic research. By embedding precautionary principles, fostering public engagement, ensuring equitable access, and enforcing robust oversight, the global scientific community can harness genetic editing’s benefits while safeguarding human dignity, biodiversity, and intergenerational rights. The development of coherent, adaptable, and enforceable ethical frameworks is not merely a regulatory necessity but a moral imperative to guide humanity through one of the most consequential frontiers in science.